• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于组织工程和再生医学应用的细胞衍生基质。

Cell-derived matrices for tissue engineering and regenerative medicine applications.

作者信息

Fitzpatrick Lindsay E, McDevitt Todd C

机构信息

Department of Chemical Engineering, Queen's University, Kingston, Canada.

The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, Georgia, USA ; The Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USA.

出版信息

Biomater Sci. 2015 Jan;3(1):12-24. doi: 10.1039/C4BM00246F.

DOI:10.1039/C4BM00246F
PMID:25530850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4270054/
Abstract

The development and application of decellularized extracellular matrices (ECM) has grown rapidly in the fields of cell biology, tissue engineering and regenerative medicine in recent years. Similar to decellularized tissues and whole organs, cell-derived matrices (CDMs) represent bioactive, biocompatible materials consisting of a complex assembly of fibrillar proteins, matrix macromolecules and associated growth factors that often recapitulate, at least to some extent, the composition and organization of native ECM microenvironments. The unique ability to engineer CDMs de novo based on cell source and culture methods makes them an attractive alternative to conventional allogeneic and xenogeneic tissue-derived matrices that are currently harvested from cadaveric sources, suffer from inherent heterogeneity, and have limited ability for customization. Although CDMs have been investigated for a number of biomedical applications, including adhesive cell culture substrates, synthetic scaffold coatings, and tissue engineered products, such as heart valves and vascular grafts, the state of the field is still at a relatively nascent stage of development. In this review, we provide an overview of the various applications of CDM and discuss successes to date, current limitations and future directions.

摘要

近年来,去细胞化细胞外基质(ECM)在细胞生物学、组织工程和再生医学领域的发展与应用迅速增长。与去细胞化组织和全器官类似,细胞衍生基质(CDM)代表了具有生物活性、生物相容性的材料,由纤维状蛋白、基质大分子和相关生长因子的复杂组合构成,这些成分通常至少在一定程度上重现了天然ECM微环境的组成和组织结构。基于细胞来源和培养方法从头设计CDM的独特能力,使其成为传统同种异体和异种组织衍生基质的有吸引力的替代物,目前这些传统基质是从尸体来源获取的,存在内在异质性,定制能力有限。尽管CDM已被研究用于多种生物医学应用,包括粘性细胞培养底物、合成支架涂层以及组织工程产品,如心脏瓣膜和血管移植物,但该领域仍处于相对初期的发展阶段。在本综述中,我们概述了CDM的各种应用,并讨论了迄今为止的成功、当前的局限性和未来的方向。

相似文献

1
Cell-derived matrices for tissue engineering and regenerative medicine applications.用于组织工程和再生医学应用的细胞衍生基质。
Biomater Sci. 2015 Jan;3(1):12-24. doi: 10.1039/C4BM00246F.
2
Decellularized orthopaedic tissue-engineered grafts: biomaterial scaffolds synthesised by therapeutic cells.去细胞化的骨科组织工程移植物:治疗细胞合成的生物材料支架。
Biomater Sci. 2018 Oct 24;6(11):2798-2811. doi: 10.1039/c8bm00772a.
3
Decellularized skeletal muscle: A versatile biomaterial in tissue engineering and regenerative medicine.去细胞化骨骼肌:组织工程和再生医学中的多功能生物材料。
Biomaterials. 2022 Apr;283:121436. doi: 10.1016/j.biomaterials.2022.121436. Epub 2022 Feb 23.
4
Recent Trends in Decellularized Extracellular Matrix Bioinks for 3D Printing: An Updated Review.近期去细胞化细胞外基质生物墨水 3D 打印技术的研究进展:最新综述。
Int J Mol Sci. 2019 Sep 18;20(18):4628. doi: 10.3390/ijms20184628.
5
Towards Biomanufacturing of Cell-Derived Matrices.迈向细胞衍生基质的生物制造。
Int J Mol Sci. 2021 Nov 3;22(21):11929. doi: 10.3390/ijms222111929.
6
Incorporation of nanoparticles into transplantable decellularized matrices: Applications and challenges.将纳米颗粒融入可移植脱细胞基质:应用与挑战。
Int J Artif Organs. 2018 Aug;41(8):421-430. doi: 10.1177/0391398818775522. Epub 2018 May 28.
7
Clinical applications of decellularized extracellular matrices for tissue engineering and regenerative medicine.脱细胞细胞外基质在组织工程和再生医学中的临床应用。
Biomed Mater. 2016 Mar 17;11(2):022003. doi: 10.1088/1748-6041/11/2/022003.
8
The application of composite scaffold materials based on decellularized vascular matrix in tissue engineering: a review.基于脱细胞血管基质的复合支架材料在组织工程中的应用:综述。
Biomed Eng Online. 2023 Jun 19;22(1):62. doi: 10.1186/s12938-023-01120-z.
9
Evolution of biomimetic ECM scaffolds from decellularized tissue matrix for tissue engineering: A comprehensive review.用于组织工程的脱细胞组织基质仿生细胞外基质支架的研究进展:综述
Int J Biol Macromol. 2023 Aug 15;246:125672. doi: 10.1016/j.ijbiomac.2023.125672. Epub 2023 Jul 3.
10
Recent development and biomedical applications of decellularized extracellular matrix biomaterials.脱细胞细胞外基质生物材料的最新发展及其在生物医学中的应用。
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109942. doi: 10.1016/j.msec.2019.109942. Epub 2019 Jul 3.

引用本文的文献

1
Synthetic scaffolds functionalized with mesenchymal stem/stromal cells-derived extracellular matrix for bone tissue engineering: a review.用于骨组织工程的间充质干/基质细胞衍生细胞外基质功能化合成支架:综述
RSC Adv. 2025 Sep 4;15(38):31812-31829. doi: 10.1039/d5ra02106e. eCollection 2025 Aug 29.
2
Recent advances in pericardium extracellular matrix for tissue regeneration, along with a short insight into artificial intelligence.用于组织再生的心包细胞外基质的最新进展,以及对人工智能的简要洞察。
Front Med Technol. 2025 Aug 14;7:1503153. doi: 10.3389/fmedt.2025.1503153. eCollection 2025.
3
Reconstructing the female reproductive system using 3D bioprinting in tissue engineering.

本文引用的文献

1
Decellularized Native and Engineered Arterial Scaffolds for Transplantation.用于移植的去细胞化天然和工程化动脉支架
Cell Transplant. 2003 Sep;12(6):659-666. doi: 10.3727/000000003108747136.
2
Dermal skin substitutes for upper limb reconstruction: current status, indications, and contraindications.用于上肢重建的真皮皮肤替代物:现状、适应证和禁忌证。
Hand Clin. 2014 May;30(2):239-52, vii. doi: 10.1016/j.hcl.2014.02.001.
3
The host response to allogeneic and xenogeneic biological scaffold materials.宿主对同种异体和异种生物支架材料的反应。
在组织工程中使用3D生物打印技术重建女性生殖系统。
Mater Today Bio. 2025 Jul 22;34:102127. doi: 10.1016/j.mtbio.2025.102127. eCollection 2025 Oct.
4
Mitochondrial Oxygen Consumption and Immunocytochemistry of Human Dental Pulp Stem Cell Following 808 nm PBM Therapy: A 3D Cell Culture Study.808纳米光生物调节疗法后人牙髓干细胞的线粒体氧消耗及免疫细胞化学:一项三维细胞培养研究
J Biophotonics. 2025 Apr 28:e70051. doi: 10.1002/jbio.70051.
5
Advances in abiotic tissue-based biomaterials: A focus on decellularization and devitalization techniques.基于非生物组织的生物材料的进展:聚焦于去细胞化和失活技术。
Mater Today Bio. 2025 Apr 6;32:101735. doi: 10.1016/j.mtbio.2025.101735. eCollection 2025 Jun.
6
Enhanced Cell Proliferation, Migration, and Fibroblast Differentiation with Electrospun PCL-Zinc Scaffolds Coated with Fibroblast-Derived ECM.涂覆有成纤维细胞衍生细胞外基质的电纺聚己内酯-锌支架增强细胞增殖、迁移和成纤维细胞分化。
ACS Omega. 2025 Jan 28;10(5):4427-4441. doi: 10.1021/acsomega.4c07504. eCollection 2025 Feb 11.
7
Understanding the Lymphatic System: Tissue-on-Chip Modeling.了解淋巴系统:芯片上组织建模。
Annu Rev Biomed Eng. 2025 May;27(1):73-100. doi: 10.1146/annurev-bioeng-110222-100246. Epub 2025 Jan 22.
8
In Vitro Engineered ECM-incorporated Hydrogels for Osteochondral Tissue Repair: A Cell-Free Approach.用于骨软骨组织修复的体外工程化含细胞外基质水凝胶:一种无细胞方法。
Adv Healthc Mater. 2025 Feb;14(4):e2402701. doi: 10.1002/adhm.202402701. Epub 2025 Jan 5.
9
LCST/UCST behavior of polysaccharides for hydrogel fabrication.用于水凝胶制备的多糖的最低临界溶液温度/最高临界溶液温度行为
RSC Adv. 2024 Nov 11;14(48):35754-35768. doi: 10.1039/d4ra06240j. eCollection 2024 Nov 4.
10
The considerations on selecting the appropriate decellularized ECM for specific regeneration demands.关于为特定再生需求选择合适的脱细胞细胞外基质的考量。
Mater Today Bio. 2024 Oct 18;29:101301. doi: 10.1016/j.mtbio.2024.101301. eCollection 2024 Dec.
J Tissue Eng Regen Med. 2015 May;9(5):504-11. doi: 10.1002/term.1874. Epub 2014 Feb 18.
4
Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival.永生化与诱导性死亡策略相结合以产生具有可控生存能力的人间充质基质细胞系。
Stem Cell Res. 2014 Mar;12(2):584-98. doi: 10.1016/j.scr.2013.12.006. Epub 2013 Dec 27.
5
Enhanced ex vivo expansion of adult mesenchymal stem cells by fetal mesenchymal stem cell ECM.通过胎儿间充质干细胞细胞外基质增强成人间充质干细胞的体外扩增。
Biomaterials. 2014 Apr;35(13):4046-57. doi: 10.1016/j.biomaterials.2014.01.081. Epub 2014 Feb 21.
6
Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.异种支架生成中的免疫原性:抗原去除与脱细胞处理
Acta Biomater. 2014 May;10(5):1806-16. doi: 10.1016/j.actbio.2014.01.028. Epub 2014 Jan 31.
7
Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery.去细胞化后完全生物工程化移植物在绵羊股动脉中的植入。
Tissue Eng Part A. 2014 Jun;20(11-12):1726-34. doi: 10.1089/ten.TEA.2013.0550. Epub 2014 Feb 25.
8
Human acellular dermal wound matrix: evidence and experience.人脱细胞真皮伤口基质:证据与经验。
Int Wound J. 2015 Dec;12(6):646-54. doi: 10.1111/iwj.12185. Epub 2013 Nov 28.
9
First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access.首例同种异体组织工程血管移植物用于血液透析通路的人体应用。
J Vasc Surg. 2014 Nov;60(5):1353-1357. doi: 10.1016/j.jvs.2013.08.018. Epub 2013 Oct 5.
10
Tubular heart valves from decellularized engineered tissue.来自脱细胞工程组织的管状心脏瓣膜。
Ann Biomed Eng. 2013 Dec;41(12):2645-54. doi: 10.1007/s10439-013-0872-9. Epub 2013 Jul 30.